Barclays Forecasts Strong Price Appreciation for Cognex (NASDAQ:CGNX) Stock

Cognex (NASDAQ:CGNX) had its price objective hoisted by equities researchers at Barclays from $80.00 to $85.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the scientific and technical instruments company’s stock. Barclays‘s price target indicates a potential upside of 37.60% from the stock’s previous close.

Several other analysts have also commented on CGNX. DA Davidson reaffirmed a “neutral” rating and set a $65.00 price target on shares of Cognex in a research report on Wednesday, September 23rd. The Goldman Sachs Group reiterated a “buy” rating and issued a $91.00 price objective on shares of Cognex in a research report on Friday, August 7th. Weiss Ratings raised Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. Cantor Fitzgerald lifted their target price on Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Finally, Needham & Company LLC restated a “buy” rating and issued a $80.00 target price on shares of Cognex in a research report on Tuesday, September 15th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cognex has an average rating of “Moderate Buy” and an average target price of $75.57.

Cognex Price Performance

Shares of CGNX traded down $1.15 during mid-day trading on Monday, reaching $61.77. The stock had a trading volume of 546,671 shares, compared to its average volume of 2,129,634. Cognex has a 52-week low of $34.60 and a 52-week high of $72.88. The firm has a market cap of $10.39 billion, a price-to-earnings ratio of 60.04 and a beta of 1.48. The business’s fifty day moving average is $62.18 and its 200 day moving average is $61.36.

Cognex (NASDAQ:CGNX) last issued its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.42 by $0.03. The company had revenue of $291.26 million for the quarter, compared to the consensus estimate of $292.10 million. Cognex had a net margin of 16.05% and a return on equity of 13.50%. Cognex’s quarterly revenue was up 16.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.25 earnings per share. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, sell-side analysts anticipate that Cognex will post 1.68 EPS for the current fiscal year.

Institutional Investors Weigh In On Cognex

Institutional investors and hedge funds have recently made changes to their positions in the stock. Wedmont Private Capital raised its position in Cognex by 7.8% in the third quarter. Wedmont Private Capital now owns 5,196 shares of the scientific and technical instruments company’s stock valued at $316,000 after purchasing an additional 374 shares during the period. Legacy Wealth Asset Management LLC purchased a new position in shares of Cognex during the third quarter worth $226,000. GAMMA Investing LLC boosted its position in shares of Cognex by 47.7% during the third quarter. GAMMA Investing LLC now owns 9,099 shares of the scientific and technical instruments company’s stock worth $552,000 after buying an additional 2,937 shares during the period. Elevation Wealth Partners LLC boosted its position in shares of Cognex by 86.6% during the third quarter. Elevation Wealth Partners LLC now owns 892 shares of the scientific and technical instruments company’s stock worth $54,000 after buying an additional 414 shares during the period. Finally, Congress Asset Management Co. acquired a new stake in shares of Cognex in the third quarter valued at $23,624,000. 88.12% of the stock is owned by hedge funds and other institutional investors.

About Cognex

Cognex Corporation (NASDAQ: CGNX) develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company’s product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.